Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on protein therapeutics market provides in-depth
analysis of segments and sub-segments in the global as well as regional protein
therapeutics market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional protein
therapeutics market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecasts, and dollar values of the global
protein therapeutics market. According to the report, the global protein therapeutics
market is projected to grow at a CAGR of 6.24% over the forecast period of
2020-2026.
It allows for an individualized
approach to treatment by promoting a specifically targeted therapeutic process
by compensating for the deficiency of an essential protein. It also helps
minimize the effects of illness or chemotherapy; it may also improve the
body's supply of a beneficial protein. Therapeutic proteins are used to treat an
extensive range of diseases such as protein deficiency diseases, rheumatoid
arthritis (RA), diabetes, chronic diseases such as cancer, infections such as
human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C;
and other medical conditions such as genetic disorders, anemia cases related to
kidney dialysis, and cancer-related anemia. Protein therapeutics mostly consist
of recombinant forms of naturally occurring proteins. The COVID-19 outbreak and
the containment measures introduced by the government have severely affected
the drug development and pharmaceutical sector. The virus has brought many
uncertainties such as supply chain disruption, and raw material unavailability
owing to stringent government regulations. However, Molecular Partners AG, a
Switzerland-based clinical-stage biotechnology organization, is developing
another class of protein therapeutics, called DARPin, to restrain the
multiplication of the infection. Therefore, the unexpected occurrence of the COVID-19
will further providing development opportunities for the market players in the
upcoming years.
Advancements in biological
sciences have shown a positive influence on the global protein therapeutics
market. There are novel technological advancements in terms of drug
manufacture, development, and delivery. Also, the future landscape of the
market is expected to be promising as there are novel products in the pipeline
that are expected to revolutionize the market globally. However, protein
therapeutics are expensive and cannot be afforded by all, but reimbursement of
diagnostic kits and biologic drugs is expected to fuel the market during the
forecast period. The increasing demand for costly drugs is an important reason
for these drugs to be included in reimbursement plans. Plans such as public
reimbursement programs reduce the financial burden of treatments and driving
the demand for these therapeutics. On the other hand, complexities in
manufacturing, storage conditions, and distribution policies affect the growth
of the market. Nevertheless, the increasing usage of next-generation mAbs in
treating diseases will have a positive impact on the market.
Among the regions, North America
holds a major share in the global protein therapeutics market. The US is a key
revenue generator in the North American protein therapeutics market. Factors
such as the rising prevalence of cardiovascular diseases and the presence of
major key players in this region increase demand for the protein therapeutics
market. Further, Asia Pacific will witness rapid growth in the forecast period
owing to the increasing purchasing power of consumers and rapid growth in the
healthcare sector in emerging countries such as China, Japan, and India.
The report on the global protein therapeutics
market covers segments such as protein function and product type. On the basis
of protein function, the sub-markets include vaccines, enzymatic and
regulatory, and protein diagnostics. On the basis of product type, the
sub-markets include insulin, erythropoietin, monoclonal antibodies, G-CSF,
interferons, follicle stimulating hormone, and blood clotting factor.
The report provides profiles of
the companies in the market such as Baxter International, F. Hoffmann-La Roche,
Merck, AbbVie, Eli Lilly, Generex Biotechnology, Amgen, Novo Nordisk, Johnson
& Johnson, and Pfizer.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the protein therapeutics market. Moreover, the study highlights current
market trends and provides forecasts from 2020-2026. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.
Please Choose One of them.